Clinical Professor, Department of Family and Community Medicine
Biosketch
Dr. Ruoff received his Bachelor of Science degree in Chemistry and Biology from St. Peter’s College in New Jersey. He received his Doctor of Medicine degree from Stritch School of Medicine-Loyola University in 1965. He is Board Certified by the American Board of Family Practice and is currently a member of the American Academy of Family Physicians and Michigan State Medical Society. Dr. Ruoff is also Board Certified by the National Board for Headache Management.
Dr. Ruoff is one of four founding physicians of Westside Family Medical Center, P.C. which was founded at its current location in June of 1971. Dr. Ruoff is the Medical Director and Principal Investigator of Clinical Research at Westside Family Medical Center, P.C. Dr. Ruoff is a leader in the area of Clinical Research and has received numerous awards for his work in this area. Dr. Ruoff has also published many articles based on his work and expertise. Dr. Ruoff is a Clinical Professor with the Department of Family and Community Medicine at Western Michigan University Homer Stryker M.D. School of Medicine and has held many positions within the American Academy of Family Physicians.
-
Board Certification
- American Board of Family Medicine (Family Medicine)
-
Education and Training
- Internship 1966, Borgess Hospital - Kalamazoo, MI,
- MD 1965, Stritch School of Medicine, Loyola University-Chicago
- BS 1961, Chemistry and Biology, Saint Peter's College
-
Research
- Family Medicine
-
Publications
Wiviott S.D., Raz I., Bonaca M.P., Mosenzon O., Kato E.T., Cahn A., Silverman M.G., Zelniker T.A., Kuder J.F., Murphy S.A., Bhatt D.L., Leiter L.A., McGuire D.K., Wilding J.P.H., Ruff C.T., Nilsson G.I., Fredriksson M., Johansson P.A., Langkilde A.M., Sabatine M.S., Bansilal S., Furtado R., Fish M.P., Gabovitch D., Jevne A., Ahern S., Im K., Goodrich E.L., Lowe C., Fisher N., Gannon J., Trindade S., Towarowski A., Fox Y., Johnsson E., Ranft S., Faber B., Wallander M., Weiss A., Buskila A., Abola M.T.B., Ardissino D., Averkov O., Aylward P., Bode C., Bonnici F., Bonora E., Budaj A., Cernea S., Chiang C.E., Cooper M., Dalby A., Deerochanawong C., Dellborg M., Diaz R., Dimulescu D., Eliaschewitz F.G., Goudev A.R., Hadjadj S., Herrera M., Huo Y., Jermendy G., Ji L., Kadowaki T., Kiss R., Kooy A., Kumar K.M.P., Lewis B., Litwak L., Lopez-Sendon J., Ma R., Merlini P.A., Nauck M.A., Nguyen T.K., Nicolau J.C., Ostgren C.J., Ophuis T.O., Padilla F., Pais P., Park K.S., Parkhomenko A., Ray K., Rosenstock J., Ruda M., Satman I., Shestakova M., Smahelova A., Spinar J., Strojek K., Sy R., Tankova T., Theroux P., Tkáč I., Van Gaal L., Wainstein J., Harrington R.A., Droller M.J., Lee K.L., Nesto R.W., Tuomilehto J. Dapagliflozin and cardiovascular outcomes in type 2 diabetes New England Journal of Medicine. 2019;380:347-357.
Bohula E.A., Scirica B.M., Inzucchi S.E., McGuire D.K., Keech A.C., Smith S.R., Kanevsky E., Murphy S.A., Leiter L.A., Dwyer J.P., Corbalan R., Hamm C., Kaplan L., Nicolau J.C., Ophuis T.O., Ray K.K., Ray K.K., Ruda M., Spinar J., Patel T., Miao W., Perdomo C., Francis B., Dhadda S., Bonaca M.P., Ruff C.T., Sabatine M.S., Wiviott S.D., Inzucchi S., Satlin A., Brown C., Budaj A., Dwyer J., Garcia-Castillo A., Gupta M., Oude Ophuis T., Weissman N., White H.D., Amerena J., Arstall M., Colquhoun D., Jayasinghe R., Lee A., Lehman R., Moses R., Proietto J., Purnell P., Waites J., Blombery P., Cross D., Worthley M., d'Emden M., Selvanayagam J., Oqueli R.E., Whelan A., Garrahy P., de Looze F., Ninio D., Horowitz J., William M., Suranyi M., Wittert G., Le May M., Pandey A.S., Vizel S., Labonte R., Beaudry Y., Fortin C., Bell A., Kouz S., St-Amour , Bata I., St Maurice F., Chehayeb R., Constance C., Wong G., Hess A., Liutkus J., Poirier P., Teitelbaum I., Berlingieri J., Cha J., Hartleib M., Heffernan M., Twum-Barima D., Pandith V., Aronson R., Goldenberg R., Ajala B., Jain A., Ross S., Bajaj H., Khandwala H., Yared Z., Gupta N., Bédard J., Wharton S., Blouin F., Savard D., Shukla D. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial The Lancet. 2018;392:2269-2279.
Ridker P.M., Revkin J., Amarenco P., Brunell R., Curto M., Civeira F., Flather M., Glynn R.J., Gregoire J., Jukema J.W., Karpov Y., Kastelein J.J.P., Koenig W., Lorenzatti A., Manga P., Masiukiewicz U., Miller M., Mosterd A., Murin J., Nicolau J.C., Nissen S., Ponikowski P., Santos R.D., Schwartz P.F., Soran H., White H., Wright R.S., Vrablik M., Yunis C., Shear C.L., Tardif J.C., Conde D., Colquhoun D., Missault L., Grégoire J., Gao R., Urina M., Solar M., Jensen H.K., Grobbee D., Savolainen M., Schiele F.N., Montalescot G., Edes I., Blake G., Lotan C., Maggioni A., Savonitto S., Lee C.W., Leiva Pons J.L., Dan G.A., Cortada J.B., Mellbin L., Kahan T., Noble S., Hwang J.J., Sritara P., Tökgozoğlu L., Tarasenko L., Borer J.S., Black H., Carmena R., Furie K.L., McMurray J., Neaton J., Zannad F., O’Neill B., Welty F., McNamara R., Chun H., Abbott J.D., Jacoby D., McPherson C., Jadbabaie F., Pinto D., McCullough L., Silverman I.E., Sansing L.H., Dearborn-Tomazos J., Foody J., Schindler J., Piazza G., Chakrabarti A., Pride Y., Gelfand E., Baultrukonis D., Chaudhuri S., Frederich R., Johnson M., Mridha K., Powell C., Wang E., Wei C., Anderson P., Buonanno M., Epsley C., Evans B., Frolova M., Goetsch M., Hessinger D. Cardiovascular efficacy and safety of bococizumab in high-risk patients New England Journal of Medicine. 2017;376:1527-1539.
Ruoff G., Edwards N. Overview of Serum Uric Acid Treatment Targets in Gout: Why Less Than 6 mg/dL? Postgraduate Medicine. 2016;128(7):706-715.
Ruoff G. Hot Topics in Primary Care: Nonsteroidal Anti- inflammatory Drugs and Cardiovascular Risk: Where Are We Today? The Journal of family practice. 2015;64(12):S67-S70.
Ruoff G. Rheumatoid arthritis: Early treatment with corticosteroids and nonsteroidal anti-inflammatory drugs Journal of Family Practice. 2014;63(2)
Giugliano R.P., Ruff C.T., Braunwald E., Murphy S.A., Wiviott S.D., Halperin J.L., Waldo A.L., Ezekowitz M.D., Weitz J.I., Špinar J., Ruzyllo W., Ruda M., Koretsune Y., Betcher J., Shi M., Grip L.T., Patel S.P., Patel I., Hanyok J.J., Mercuri M., Antman E.M., Peruzzotti-Jametti L., Malynovsky Y., Morin S.E., Hoffman E.B., Deenadayalu N., Lanz H., Curt V., Duggal A., Davé J., Morgan D., Choi Y., Jin J., Xie J., Crerand W., Kappelhof J., Maxwell W., Skinner M., Selicato G., Otto C., Reissner C., Smith K., Ostroske J., Ron A., Connolly S., Camm J., Paolasso E., Aylward P., Heidbuchel H., Nicolau J.C., Goudev A., Roy D., Corbalán R., Yang Y., Botero R., Bergovec M., Grande P., Hassager C., Voitk J., Huikuri H., Nieminen M., Blanc J.J., LeHeuzey J.Y., Mitrovic V., Alexopoulos D., Sotomora G., Kiss R., SomaRaju B., Lewis B., Merlini P., Metra M., Yamashita T., García-Castillo A., Ophuis T., White H., Atar D., Horna M., Babilonia N., Morais J., Dorobantu M., Ostojic M., Duris T., Dalby A., Chung N., Zamorano J.L., Juul-Möller S., Moccetti T., Chen S.A., Sritara P., Oto A., Parkhomenko A., Senior R., Verheugt F., Skene A., Anderson J., Bauer K., Easton J.D., Goto S., Lowe C. Edoxaban versus warfarin in patients with atrial fibrillation New England Journal of Medicine. 2013;369:2093-2104.
Ruoff G. The treatment of gout. The Journal of family practice. 2012;61(6 Suppl)
Silberstein S., Cady R., Ruoff G., Krishen A., Peykamian M. Sumatriptan-naproxen and butalbital: A double-blind, placebo-controlled crossover study Headache. 2012;52(4):530-543.
Landy S.H., Farmer K., Juhász M., Tarrasch J., Runken M.C. Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response survey Headache. 2011;51(6):961-970.
Mccarberg B., Ruoff G., Tenzer-Iglesias P., Weil A. Diagnosis and Treatment of Low-Back Pain Because of Paraspinous Muscle Spasm: A Physician Roundtable Pain Medicine. 2011;12(SUPPL.4)
Becker M., Ruoff G. What do i need to know about gout? Journal of Family Practice. 2010;59(6)
Weil A., Ruoff G., Nalamachu S., Altman C., Xie F., Taylor D. Efficacy and tolerability of cyclobenzaprine extended release for acute muscle spasm: A pooled analysis Postgraduate Medicine. 2010;122(4):158-169.
Fennerty M.B., Finke K.B., Kushner P.R., Peura D.A., Record L., Riley L., Ruoff G.E., Simonson W., Wright W.L. Short- and long-term management of heartburn and other acid-related disorders: Development of an algorithm for primary care providers Journal of Family Practice. 2009;58(7)
Malanga G., Ruoff G., Weil A., Altman C., Xie F., Borenstein D. Cyclobenzaprine ER for muscle spasm associated with low back and neck pain: Two randomized, double-blind, placebo-controlled studies of identical design Current Medical Research and Opinion. 2009;25(5):1179-1196.
Ruoff G. Gout: Update on therapy Consultant. 2009;49(1)
Yawn B., Mannino D., Littlejohn T., Ruoff G., Emmett A., Raphiou I., Crater G. Prevalence of COPD among symptomatic patients in a primary care setting Current Medical Research and Opinion. 2009;25(11):2671-2677.
Brown J.S., Neumann P.J., Papadopoulos G., Ruoff G., Diamond M., Menzin J. Migraine frequency and health utilities: Findings from a multisite survey Value in Health. 2008;11(2):315-321.
Ruoff G.E. Gout: Clues to clinical diagnosis Consultant. 2008;48(13)
Bingham C., Sebba A., Rubin B., Ruoff G., Kremer J., Bird S., Smugar S., Fitzgerald B., O'Brien K., Tershakovec A. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies Rheumatology. 2007;46(3):496-507.
Bond J., Brady W.J., Bryan C.S., Carlson W.D., Carr D., Cayley W., Champagne B.J., Chancellor M.B., Chavda D.V., Cherner R., Cohn P.F., Connolly J.F., Conrad D.A., Effron D., Enam S.A., Farmer R.G., Fields H.J., Fitzgerald F.T., Florence J., Frank P., Friedman E.A., Garzarelli D.M., Ghatan R., Gleich P., Golden D.B.K., Grin C.M., Harrigan R.A., Hay J.W., Heffron W.A., Heidelbaugh J.J., Hellinger M.D., Herrera J.L., Ilowite J., Joseph J., Kamat D.M., Kaplan D.L., King S.A., Kirchner J.T., Klein L.W., Kountz D.S., Kramer H.M., Leach R.E., Leung A.K.C., Lieberman D., Lieberman J.A., Lombardo D., Margolis S., Matteson E.L., McCain G.A., McConnell R.Y., Mitchell J., Mochan E., Moonis M., Mosby J., Murphy D.P., Nash D.B., Nash D.T., Olshansky B., Ornato J.P., Parker R.A., Parthemore J.G., Pearsall IV A.W., Peters B., Petty T., Picco M.F., Pires L., Prisant L.M., Quick G., Rakel R.E., Reisman R., Reynolds W., Rogers J.G., Rogers R.J., Rose S.R., Rosen T., Rothe M.J., Rubin R.N., Ruderman E.M., Ruoff G.E., Rutecki G.W., Sachs H., Samraj G.P.N., Schindler J., Schmidt J.D., Schneiderman H., Shahady E.J., Skorin L., Skrabal M. Our thanks to reviewers in 2007 Consultant. 2007;47(14):1203.
McKenney J.M., Jones P.H., Bays H.E., Knopp R.H., Kashyap M.L., Ruoff G.E., McGovern M. Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study) Atherosclerosis. 2007;192(2):432-437.
Winner P., Cady R.K., Ruoff G.E., Frishberg B.M., Alexander W.J., Zhang Y., Kori S.H., Lener S.E. Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine Mayo Clinic Proceedings. 2007;82(1):61-68.
Ekman E.F., Ruoff G., Kuehl K., Ralph L., Hormbrey P., Fiechtner J., Berger M.F. The COX-2 specific inhibitor valdecoxib versus tramadol in acute ankle sprain: A multicenter randomized, controlled trial American Journal of Sports Medicine. 2006;34(6):945-955.
Kaniecki R., Ruoff G., Smith T., Barrett P., Ames M., Byrd S., Kori S. Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headache Current Medical Research and Opinion. 2006;22(8):1535-1544.
Petruschke R., Chang D., Tershakovec A. Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies Current Medical Research and Opinion. 2006;22(1):199-210.
Ranhosky A., Davidai G., Ruoff G. Efficacy and safety of tamsulosin for benign prostatic hyperplasia: Clinical experience in the primary care setting Current Medical Research and Opinion. 2006;22(4):721-730.
Ruoff G. Combination therapy in acute migraine treatment: the rationale behind the current treatment options. Postgraduate medicine. 2006;Spec No:20-26.
Ruoff G. Depression and migraine: To what extent is migraine a marker for increased prevalence of selected comorbidities? Headache and Pain: Diagnostic Challenges, Current Therapy. 2006;17(2):68-72.
Ruoff G. Effective pharmacologic strategies for treatment and prevention of migraine Drug Benefit Trends. 2006;18(5):300-308.
Ruoff G.E. Chronic daily headache triggers: It's not what you take - But how often that counts Headache and Pain: Diagnostic Challenges, Current Therapy. 2006;17(2):91.
Ruoff G.E. Early intervention in a case of migraine with depression Consultant. 2006;46(4):429-431.
Ruoff G.E. Evidence-based cardiovascular disease prevention and risk assessment Drug Benefit Trends. 2006;18(9):495-502.
Kudrow D., Thomas H.M., Ruoff G., Ishkanian G., Sands G., Le V.H., Brown M.T. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache Headache. 2005;45(9):1151-1162.
Ruoff G. A method that dramatically improves patient adherence to depression treatment Journal of Family Practice. 2005;54(10):846-852.
Ruoff G.E. Chronic daily headache triggers: It's not what you take but how often that counts Consultant. 2005;45(12):1245.
Ruoff G.E. Chronic daily headache: Understanding and treatment Consultant. 2005;45(8):871-886.
Ruoff G.E. Early intervention in a case of migraine with depression Headache and Pain: Diagnostic Challenges, Current Therapy. 2005;16(3)
Ruoff G.E. Evidence-based cardiovascular disease prevention: Challenges to assessing risk in office practice Consultant. 2005;45(13):1467-1474.
Ruoff G.E. Understanding and treating chronic daily headache Headache and Pain: Diagnostic Challenges, Current Therapy. 2005;16(1):39-48.
Ruoff G. Migraine comorbidity: Consequent pharmacologic strategies for treatment Consultant. 2004;44(4):638-646.
Ruoff G. Migraine: Effective pharmacologic strategies for prevention and treatment Headache and Pain: Diagnostic Challenges, Current Therapy. 2004;15(2):75-82.
Ruoff G. Migriane Comorbidity: Consequent Pharmacologic Strategies for Treatment Headache and Pain: Diagnostic Challenges, Current Therapy. 2004;15(1):9-15.
Ruoff G. Trigger point injections: What to expect Consultant. 2004;44(2):208.
Ruoff G.E. Benign or worrisome headache? Keys to making the diagnosis Headache and Pain: Diagnostic Challenges, Current Therapy. 2004;15(3):109-113.
Ruoff G.E. Headache: Benign or worrisome? Keys to making the diagnosis Consultant. 2004;44(12):1581-1584.
Ruoff G.E. Migraine: Effective pharmacologic strategies for prevention and treatment Consultant. 2004;44(7):969-975.
Shaker R., Brunton S., Elfant A., Golopol L., Ruoff G., Stanghellini V. Review article: Impact of night-time reflux on lifestyle - Unrecognized issues in reflux disease Alimentary Pharmacology and Therapeutics, Supplement. 2004;20(9):3-13.
Quinn J., Ruoff G., Ziter P. Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: A multicenter, randomized, double-blind, parallel-group study Clinical Therapeutics. 2003;25(2):422-443.
Ruoff G. Trigger point injections: A primary care intervention Consultant. 2003;43(2):213-221.
Ruoff G. Woman with Intense Daily Headaches Headache and Pain: Diagnostic Challenges, Current Therapy. 2003;14(3):134-137.
Ruoff G., Lema M. Strategies in pain management: New and potential indications for COX-2 specific inhibitors Journal of Pain and Symptom Management. 2003;25(2 SUPPL.):21-31.
Ruoff G., Rosenthal N., Jordan D., Karim R., Kamin M. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: A multicenter, randomized, double-blind, placebo-controlled outpatient study Clinical Therapeutics. 2003;25(4):1123-1141.
Ruoff G. Challenges of managing chronic pain in the elderly Seminars in Arthritis and Rheumatism. 2002;32(3 SUPPL. 1):43-50.
Ruoff G. Effects of flow sheet implementation on physician performance in the management of asthmatic patients Family Medicine. 2002;34(7):514-517.
Ruoff G. Emerging therapies for rheumatoid arthritis Drug Benefit Trends. 2002;14(SUPPL. B):6-12.
Ruoff G. Rheumatoid arthritis: Emerging treatments Consultant. 2002;42(3):297-306.
Ruoff G.E. Assessing pain as the fifth vital sign. Postgraduate medicine. 2002;112(1 Suppl):4-7.
Ruoff G.E. Introduction: The ABCs of Musculoskeletal Pain. Postgraduate medicine. 2002;112(1 Suppl):3.
Thisted R.A., Jones T.M., Barbarash R.A., Mikolich D., Ruoff G.E., Jorizzo J.L., Gunnill L.B., Katz D.H., Khalil M.H., Morrow P., Yakatan G., Pope L.E., Berg J.E. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial Journal of the American Academy of Dermatology. 2001;45(2):222-230.
Henry D., Ruoff G., Rhudy G., Puopolo A., Drehobl M., Schoenberger J., Giguere G., Collins J. Effectiveness of a short course (5 days) of treatment with cefuroxime axetil (zinnat) in secondary bacterial infections in active bronchitis Pediatriya. 2000;40(4):55.
Richard G.A., DeAbate C.A., Ruoff G.E., Corrado M., Fowler C.L., Morgan N. A double-blind, randomized trial of the efficacy and safety of short-course, once-daily levofloxacin versus ofloxacin twice daily in uncomplicated urinary tract infections Infectious Diseases in Clinical Practice. 2000;9(8):323-329.
Ruoff G.E. Zanamivir for the management of influenza Current Therapeutic Research - Clinical and Experimental. 2000;61(11):752-769.
Henry D., Ruoff G., Noonan M., DeAbate C., Puopolo A., Bettis R., Burroughs S., Cobb M., Holley H. Comparison of the efficacy and tolerability of short-course cefuroxime axetil and amoxicillin/clavulanic acid in the treatment of secondary bacterial infections of acute bronchitis Clinical Drug Investigation. 1999;18(5):335-344.
Ruoff G. Management of the mild-to-moderate migraine Headache Quarterly. 1999;10(1 SUPPL.):19-20.
Ruoff G. Shifting the focus from migraine attacks to migraineurs Headache Quarterly. 1999;10(2):117-118.
Ruoff G. Slowing the initial titration rate of tramadol improves tolerability Pharmacotherapy. 1999;19(1 I):88-93.
Ruoff G., Gray L.S. Using a flow sheet to improve performance in treatment of elderly patients with type 2 diabetes Family Medicine. 1999;31(5):331-336.
Ruoff G.E. Strategies to control chronic musculokeletal pain: Part 1, work-up and nondrug therapy Consultant. 1999;39(9):2561-2571.
Ruoff G.E. Strategies to control chronic musculoskeletal pain: A guide to drug therapy Consultant. 1999;39(10):2773-2781.
Sperling M., Black D., Cichon M., Kassman N., Littlejohn T., Newman J., Markel W., Dorfner S., Garofalo J., Given J., Ondrejicka J., Patron A., Stoker K., Sundwall P., Adelglass J., Champlin J., Krause H., Bonnet J., Cosmo L., Imam A., Thompson B., Casale T., Garner E., Maggiacomo F., Ruoff G., Flenniken R., Puopolo A., Morin D., DeAbate C., Patrick K., Klimas J., Kaliner M., Kessler C., Orchard D. The efficacy and tolerability of moxifloxacin compared to trovafloxacin in the treatment of acute sinusitis Today's Therapeutic Trends. 1999;17(4):303-319.
Adelglass J., Jones T.M., Ruoff G., Kahn J.B., Wiesinger B.A., Rielly-Gauvin K., Siu C.O. A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis Pharmacotherapy. 1998;18(6 I):1255-1263.
Rauck R., Gargiulo C., Ruoff G., Schnitzer T., Trapp R. Chronic low back pain: new perspectives and treatment guidelines for primary care: Part I. Managed care interface. 1998;11(2)
Rauck R., Gargiulo C., Ruoff G., Schnitzer T., Trapp R. Chronic low back pain: new perspectives and treatment guidelines for primary care: Part II. Managed care interface. 1998;11(3):71-75.
Ruoff G. Management of pain in patients with multiple health problems: A guide for the practicing physician American Journal of Medicine. 1998;105(1 B):53S-60S.
Ruoff G. Upper respiratory tract infections in family practice Pediatric Infectious Disease Journal. 1998;17(8 SUPPL.)
Ruoff G.E. The impact of nonsteroidal anti-inflammatory drugs on hypertension: Alternative analgesics for patients at risk Clinical Therapeutics. 1998;20(3):376-387.
Ruoff G. Sustained normotension in hypertensive patients withdrawn from medication for 1 year Family Medicine. 1997;29(5):344-346.
Ruoff G.E. When sinus headache isn't sinus headache Headache Quarterly. 1997;8(1):22-31.
Lipton R.B., Raskin N., Ruoff G., Saper J., Sheftell F., Solomon S., Henrich W.L. Over-the-counter analgesics and kidney disease American Journal of Kidney Diseases. 1996;27:917-918.
Ruoff G. Erratum: Recurrent streptococcal pharyngitis (Postgraduate Medicine (February) (220)) Postgraduate Medicine. 1996;99(5):46.
Ruoff G. Recurrent streptococcal pharyngitis: Using practical treatment options to interrupt the cycle Postgraduate Medicine. 1996;99(2):211-222.
Ruoff G. Some patients with hypertension can withdraw from medication American Family Physician. 1996;54(8):2523.
Ruoff G.E. Depression in the patient with chronic pain Journal of Family Practice. 1996;43(6 SUPPL.)
Henry D., Ruoff G., Rhudy J., Puopolo A., Drehobl M., Schoenberger J., Giguere G., Collins J. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis Clinical Therapeutics. 1995;17(5):861-874.
Henry D., Ruoff G., Rhudy J., Puopolo A., Drehobl M., Schoenberger J., Giguere G., Collins J. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis Antimicrobial Agents and Chemotherapy. 1995;39(11):2528-2534.
Ruoff G. Chronic pain in primary care Headache Quarterly. 1995;6(1):19-25.
Thompson K., Ruoff G.E., Imig J.R., Lane P., Schwenker C.E., Wilson P., Wilkins L., Ford C., Sharp P., Snyder F., Cochran J., Ross P., Kletzky O., Suh B., Cabus E., Notelowitz M., Breen M., Bayne B. Efficacy and safety of a seven-day, transdermal estradiol drug-delivery system: Comparison with conjugated estrogens and placebo International Journal of Fertility and Menopausal Studies. 1995;40(3):126-134.
Rauck R.L., Ruoff G.E., McMillen J.I. Comparison of tramadol and acetaminophen with codeine for long-term pain management in elderly patients Current Therapeutic Research. 1994;55(12):1417-1431.
Ruoff G. Headache in elderly patients: How to recognize and manage benign types Postgraduate Medicine. 1993;94(8):109-121.
Ruoff G. The management of non-insulin-dependent diabetes mellitus in the elderly Journal of Family Practice. 1993;36(3):329-335.
Ruoff G.E. Primary care role in headache management Headache Quarterly. 1993;4(2):145-150.
Dere W., Farlow D., Therasse D.G., Ruoff G.E. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis Clinical Therapeutics. 1992;14(1):41-53.
McCarty J., Ruoff G., Jacobson K. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population The American Journal of Medicine. 1992;92(6 SUPPL. 1)
Williams R.L., Goyle K.K., Herman T.S., Rofman B.A., Ruoff G.E., Hogan L.B. Dose‐Dependent Effects of Betaxolol in Hypertension: A Double‐Blind, Multicenter Study The Journal of Clinical Pharmacology. 1992;32(4):360-367.
Ruoff G.E. Reducing fat intake with fat substitutes American Family Physician. 1991;43:1235-1242.
Rubin P., Yee J.P., Ruoff G. Comparison of long-term safety of ketorolac tromethamine and aspirin in the treatment of chronic pain Pharmacotherapy. 1990;10
Ruoff G. ACE inhibitors and diuretics. The benefits of combined therapy for hypertension Postgraduate Medicine. 1989;85(3):127-139.
Tuck M.L., Katz L.A., Kirkendall W.M., Koeppe P.R., Ruoff G.E., Sapir D.G. Low-dose captopril in mild to moderate geriatric hypertension GeriatRx. 1989;1:13-17.
Guthrie R.M., Ruoff G.E., Rofman B.A., Ginsberg D., Karp R.R., Brown S.M., Shul G.A. Aetiology of acute pharyngitis and clinical response to empirical therapy with erythromycin versus amoxicillin Family Practice. 1988;5(1):29-35.
Sabesin S.M., Boyce H.W., King C.E., Mann J., Ruoff G., Wall E. Comparative Evaluation of Gastrointestinal Intolerance Produced by Plain and Tri‐Buffered Aspirin* Tablets The American Journal of Gastroenterology. 1988;83(11):1220-1225.
Ruoff G. Peptic ulcer disease. The role of the primary care physician in therapeutic intervention Postgraduate Medicine. 1987;81(5):85-90.
Ruoff G. Prolonged normotension after abrupt withdrawal of terazosin treatment. Implications for studies of the efficacy of antihypertensive drugs Journal of Clinical Research and Drug Development. 1987;1(4):293-300.
Ruoff G. Comparative trials of terazosin with other antihypertensive agents The American Journal of Medicine. 1986;80(5 SUPPL. 2):42-48.
Ruoff G. Effect of withdrawal of terazosin therapy in patients with hypertension The American Journal of Medicine. 1986;80(5 SUPPL. 2):35-41.
Ruoff G.E. The pain of osteoarthritis The American Journal of Medicine. 1986;80(3 SUPPL. 1):96.
Tuck M.L., Kirkendall W.M., Koeppe P.R., Ruoff G.E., Sapir D.G. Low‐Dose Captopril in Mild to Moderate Geriatric Hypertension Journal of the American Geriatrics Society. 1986;34:693-696.
Ruoff G., Beery G. Chronic pain. Characteristics, assessment, and treatment plans Postgraduate Medicine. 1985;78(4):91-97.
Ruoff G. Treatment of the chronic pain of osteoarthritis: Zomepirac versus aspirin Current Therapeutic Research - Clinical and Experimental. 1982;32(5):638-645.
Cannella J. Long-term safety of zomepirac: A double-blind comparison with aspirin in patients with osteoarthritis Journal of Clinical Pharmacology. 1980;20(5-6 II):377-384.
MAYER T., RUOFF G.E. Clinical Evaluation of Zomepirac in the Treatment of Acute Orthopedic Pain The Journal of Clinical Pharmacology. 1980;20(4):285-291.
Ruoff G. Colestipol Hydrochloride for Treatment of Hypercholesterolemia in a Family Practice: Five‐Year Study Journal of the American Geriatrics Society. 1978;26(3):121-126.
Lefton T.E., Ruoff G.E., Brooks C.D. Ibuprofen in osteoarthritis Southern Medical Journal. 1977;70(1):49-52.
Gundersen K., Cooper E.E., Ruoff G., Nikolai T., Assenzo J.R. Cholesterol-lowering effect of colestipol hydrochloride given twice daily in hypercholesterolemic patients Atherosclerosis. 1976;25(2-3):303-310.
Giansiracusa J., Donaldson M., Koonce M., Lefton T., Ruoff G., Brooks C. Section 1 ibuprofen in osteoarthritis Current Medical Research and Opinion. 1975;3(8):481-484.
Melluish J.W., Brooks C.D., Ruoff G., Cross C., Sanborn E.C. Ibuprofen and Visual Function: Prospective Evaluation Archives of Ophthalmology. 1975;93(9):781-782.
Ruoff G., Panzer J.D., Atkinson W.H. The serumcidality of clindamycin palmitate. Michigan medicine. 1973;72:625-626.
Sinanian R., Ruoff G., Panzer J., Atkinson W. Streptococcal pharyngitis: a comparison of the eradication of the organism by 5- and 10-day antibiotic therapy. Current Therapeutic Research - Clinical and Experimental. 1972;14:716-720.